Singapore markets closed

Acutus Medical, Inc. (AFIB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1700-0.0021 (-1.22%)
At close: 04:00PM EDT
0.1702 +0.00 (+0.12%)
After hours: 07:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1721
Open0.1730
Bid0.1700 x 200
Ask0.0000 x 0
Day's range0.1648 - 0.1748
52-week range0.1600 - 1.0900
Volume399,974
Avg. volume2,351,885
Market cap5.052M
Beta (5Y monthly)0.20
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results

    CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023. Recent Highlights: Announced strategic realignment of resources and corporate restructuring on November 8, 2023 with the objective of optimizing financial position and maximizing free cash flow.The Continuing Operations focuses on the implementation of the business model to shift to solely support

  • GlobeNewswire

    Acutus Medical Reports Third Quarter 2023 Financial Results

    CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter revenue of $5.2 million grew 44% year-over-year, led by strong growth in distribution revenue from sales of left-heart access products to MedtronicRegistered significant year-over-year reductions in both GAAP and non-GAAP operating expenses and cash burn, resulting from disciplined focus on expen

  • GlobeNewswire

    Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring

    CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens, Chairman of Acutus, commented, “Following an extensive strategic review by the Company’s Board of Directors, we are taking the hard but necessary steps to streamline our operations. In light of the current financing environment and the capital investments required to achieve leadership in the